Endocrinology, doi:10.1210/en.2007-0312
Endocrinology Vol. 149, No. 2 461-465
Copyright © 2008 by The Endocrine Society
Caveolin-1 Down-Regulation Inhibits Insulin-Like Growth Factor-I Receptor Signal Transduction in H9C2 Rat Cardiomyoblasts
Barbara Salani,
Lucia Briatore,
Silvano Garibaldi,
Renzo Cordera and
Davide Maggi
Departments of Endocrinology and Medicine (B.S., L.B., R.C., D.M.) and Internal Medicine (S.G.), University of Genova, 5-16132 Genova, Italy
Address all correspondence and requests for reprints to: Davide Maggi, M.D., Ph.D., Department of Endocrinology and Medicine, Viale Benedetto XV, 6, University of Genova, 5-16132 Genova, Italy. E-mail: davide.maggi{at}unige.it.
Caveolin (Cav)-1, the major caveolar protein, directly interacts with IGF-I receptor (IGF-IR) and its intracellular substrates. To determine the role of Cav-1 in IGF-IR signaling, we transfected H9C2 cells with small interfering RNA specific for Cav-1-siRNA. The selective down-regulation of Cav-1 (90%) was associated with a smaller reduction of Cav-2, whereas Cav-3 expression was unaffected. A significant reduction of IGF-IR tyrosine phosphorylation in Cav-1-siRNA H9C2 cells was found compared with H9C2 control cells (Ctr-siRNA). The reduced IGF-IR autophosphorylation resulted in a decrease of insulin receptor substrate-1, Shc, and Akt activation. In addition, in Cav-1-siRNA H9C2 cells, IGF-I did not prevent apoptosis, suggesting that Cav-1 is required to mediate the antiapoptotic effect of IGF-I in cardiomyoblasts. The down-regulation of Cav-1 decreased IGF-IR activation and affected the ability of IGF-I to prevent apoptosis after serum withdrawal also in human umbilical vein endothelial cells. These results demonstrate that: 1) Cav-1 down-regulation negatively affects IGF-IR tyrosine phosphorylation; 2) this effect causes a reduced activation of insulin receptor substrate-1, Shc, and Akt; and 3) Cav-1 is involved in IGF-IR antiapoptotic signaling after serum deprivation.
Copyright © 2008 by The Endocrine Society